For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230509:nRSI8448Ya&default-theme=true
RNS Number : 8448Y Deutsche Bank AG, Frankfurt 09 May 2023
9 May 2023
Not for distribution, directly or indirectly, in or into the United States or
any jurisdiction in which such distribution would be unlawful
Notification of Stabilisation Transactions
to the Relevant Competent Authority
Deutsche Bank Aktiengesellschaft "DB" contact: Jeremy Selway, telephone +44
020 7547 5983, hereby gives notice that in relation to the offer of securities
described below, it has undertaken the following stabilisation transactions on
the dates listed below:
Issuer: Cheplapharm Arzneimittel GmbH
Guarantor if any: CheplaFinance 2 GmbH with limited recourse
If Cheplapharm Switzerland will acquire some or all of the assets subject to
the Izac Acquisition, as of the Escrow Release Date, the Notes will, subject
to certain agreed security principles, also be guaranteed on a senior basis by
Cheplapharm Switzerland.
Aggregate nominal amount: EUR 425.000.000
Description: EUR 425,000,000 Senior Secured Notes 7.50% due 2030 RegS ISIN: XS2618867159;
144A ISIN: XS2618869445
Issue/reoffer Price: 100
Spread over benchmark: +523 bps
Trading venue on which stabilisation occurred: The International Stock Exchange
**Where there is more than one trading venue, ensure that the relevant
competent authority of each trading venue is reported to as necessary.
Stabilising Managers Deutsche Bank Aktiengesellschaft
Stabilisation started: 26 April 2023
Date Time Quantity Size Currency Price B/S
UK
26/04/23 16:00 1,000,000 1,000,000 EUR 100.125 Buy
27/04/2023 14:05 1,000,000 1,000,000 EUR 100.375 Buy
27/04/2023 14:05 1,000,000 1,000,000 EUR 100.375 Buy
27/04/2023 14:40 4,000,000 4,000,000 EUR 100.375 Buy
28/04/2023 10:28 2,000,000 2,000,000 EUR 100.375 Buy
28/04/2023 16:29 3,000,000 3,000,000 EUR 100.625 Buy
02/05/2023 08:36 2,000,000 2,000,000 EUR 100.625 Buy
This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United
States. The securities referred to above have not been, and will not be,
registered under the United States Securities Act of 1933 and may not be
offered or sold in the United States absent registration or an exemption from
registration. There has not been and will not be a public offer of the
securities in the United States.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END STASSSFIUEDSEII